Skip to main content
. 2021 May 28;34:100790. doi: 10.1016/j.ijcha.2021.100790

Table 2.

Prevalence of high-risk cardiovascular conditions in athletic candidates: comparison of results from 3 recent large prospective studies that used different protocols.

Malhotra et al. [2]
(H&P, ECG, routine echo)
Williams et al. [6]
(H&P, ECG, rare echo)
Angelini et al. [3]
(H&P, ECG, s-MRI)
n (%) n (%) n (%)
Sample size 11,168 3,620 5,169
hr-CVC 42 (0.38) 15 (0.41) 76 (1.47)
hr-CMP 6 (0.05) 2 (0.06) 14 (0.27)
 DCM 1 (0.01) 0 (0.00) 11 (0.21)
 HCM 5 (0.04) 2 (0.06) 3 (0.06)
hr-ACAOS-IM 2 (0.02) 1 (0.03) 23 (0.44)
 R-ACAOS-IM 1 (0.01) 1 (0.03) 17 (0.33)
 L-ACAOS-IM 1 (0.01) 0 (0.00) 6 (0.12)
ARVC 0 (0.00) 0 (0.00) 0 (0.00)
WPW 26 (0.23) 9 (0.25) 4 (0.08)

ARVC, arrhythmogenic right ventricular cardiomyopathy; DCM, dilated cardiomyopathy; H&P, history and physical examination; ECG, electrocardiogram; Echo, echocardiogram; HCM, hypertrophic cardiomyopathy; hr-ACAOS-IM, high-risk anomalous origin of coronary artery from the opposite sinus of Valsalva with intramural course; hr-CVC, high-risk cardiovascular condition; hr-CMP, high-risk cardiomyopathy; L- ACAOS-IM, left ACAOS from the right sinus with intramural course; R-ACAOS-IM, right ACAOS from the left sinus with intermural course; s-MRI, screening cardiac magnetic resonance imaging; WPW, Wolff-Parkinson-White syndrome.

Notice the differences in favor of the diagnostic accuracy of an s-MRI-based protocol, especially regarding CAAs and DCM (p value <0.01 for MRI-based versus the other screening methods). Prolonged QTc in the THI study (Bazett criteria, see Angelini et al. [3] in Table 3) was identified by using a Philips automatic ECG device (with an electrophysiologist’s confirmation), but we do not know the criteria or methods used by the other investigators, who report some 3-times-higher prevalence.